VivoSim Labs appoints Tony Lialin as Chief Commercial Officer

VivoSim Labs, INC.

Tony Lialin appointed CCO effective Aug 11, 2025; leads go-to-market strategy for NAMkind liver/intestine 3D models.
Annual salary $360,000, sign-on bonus $10,000, target bonus up to 40% of base salary.
Granted option to purchase 40,000 shares vesting over 4 years (25% cliff at 1 yr, then quarterly).
Company cites global liver/GI in-vitro market at $641M in 2024, U.S. share 50.8% ($325M).

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.